← All diseases
Cancer
Melanoma (metastatic)
Want to be notified when there is new research on Melanoma (metastatic)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Melanoma (metastatic). View what Premium costs.
Publications and studies (1866)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neoadjuvant Therapy for Melanoma. (2026/09/01) ♡
- ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L. (2026/08/11) ♡
- Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial. (2026/08/11) ♡
- Real-World Response of Cemiplimab Immunotherapy for Treating Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma in a Tertiary UK Oncology Centre. (2026/08/10) ♡
- AKAP12 as a signal-compartmentalizing Hub across diseases: Context-dependent functions and translational potential. (2026/08/09) ♡
- Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases. (2026/08/07) ♡
- Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma. (2026/08/07) ♡
- Population-level trends in melanoma Burden, stage at diagnosis, and indirect costs in Croatia: a descriptive analysis. (2026/08/06) ♡
- Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma. (2026/08/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice. (2026/08/05) ♡
- An Integrative Morphological and Genomic Analysis With a Refined FISH Threshold and Novel Kinase Fusions in a Large Asian Cohort of Spitzoid Neoplasms. (2026/08/05) ♡
- Electrospun composite nanofibers of Sanghuangporus sanghuang polysaccharide and polyvinylpyrrolidone for assisting melanoma treatment. (2026/08/05) ♡
- Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Biological Basis of the Merlin CP-GEP Assay: Integrin Signaling and Early Metastatic Competence in Cutaneous Melanoma. (2026/08/03) ♡
- Percutaneous Hepatic Perfusion: Continuum of Nursing Care and Safety Implications for Managing Patients With Metastatic Uveal Melanoma. (2026/08/03) ♡
- EID1 blockade potentiates immunosurveillance against cancer metastasis via FPR1-mediated DC-NK crosstalk. (2026/08/03) ♡
- Factors Associated With Overall Survival and 90-Day Mortality Following Resection of Melanoma Brain Metastases. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tumor-infiltrating lymphocyte (TIL) therapy: Historical context, clinical applications, and future directions. (2026/08/01) ♡
- Patient survival prediction based on PET/CT radiomics extracted from metastatic melanoma bone lesions. (2026/08/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion. (2026/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Single Center Real-world Observational Study of Response to Dacarbazine or Dacarbazine Combinations in Metastatic Melanoma Refractory to Immunotherapy. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma. (2026/08/01) ♡
- Shear-Activated von Willebrand Factor Captures Extracellular Vesicles to Promote Platelet Activation and Metastasis. (2026/08/01) ♡
- Up to Four-Year Outcomes of Single-Fraction Stereotactic Radiosurgery for Small Brain Metastases: A Competing-Risk Analysis. (2026/08/01) ♡
- Modelling targeted therapy efficacy in NRAS mutant conjunctival melanoma. (2026/07/31) ♡
- The Rural Adult and Youth Skin protection study (RAYS): Protocol for a sun protection intervention trial in rural Utah and West Virginia sports programs. (2026/07/31) ♡
- Secondary Adrenal Insufficiency and Multisystem Endocrinopathy Following Immune Checkpoint Inhibitor Therapy. (2026/07/30) ♡
- Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit Metastases. (2026/07/29) ♡
- Development of dual-function optical microneedle lens array for skin cancer treatment by photodynamic therapy. (2026/07/29) ♡
- Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma. (2026/07/29) ♡
- Spatial hearing after auricular resection for non-melanoma skin cancer. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. PTEN Hamartoma Tumor Syndrome. (2026/07/28) ♡
- The Prognostic Role of CD8(+) Tumor-Infiltrating Lymphocyte Density in Head and Neck Mucosal Melanoma. (2026/07/28) ♡
- Rapid Hematological Profiling of the GPNMB/GRN Ratio via Bioelectronic Platform for Early Diagnosis of Parkinson's Disease. (2026/07/28) ♡
- Metastatic Melanoma with Rhabdomyosarcomatous Transdifferentiation: Two Tumors with Next-Generation Sequencing Correlation. (2026/07/28) ♡
- Adverse Events in a Randomized Trial Comparing Radiotherapy with or without Olaparib for Inflammatory Breast Cancer. (2026/07/28) ♡
- AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient. (2026/07/28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical outcomes of intrathecal anti-PD-1 therapy with or without whole-brain radiotherapy in melanoma leptomeningeal metastasis: a multicenter retrospective study. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Uveal melanoma as a stress-dependent malignancy governed by a reprogrammable stress-adaptation network. (2026/07/27) ♡
- The feast of prisoners: Confining drugs and inflammatory factors locally in tumors. (2026/07/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association. (2026/07/27) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Multiple Primary Melanomas and Metastatic Neuroendocrine Tumor in a POT1 Pathogenic Variant Carrier. (2026/07/27) ♡
- Single-Cell Dissection of the Immune Microenvironment in Intrahepatic Metastasis of Multifocal Hepatocellular Carcinoma. (2026/07/27) ♡
- Clinical Outcomes of Lenvatinib-Pembrolizumab in a High-Risk, Dual ICI-Refractory Melanoma Cohort. (2026/07/27) ♡
- Thermosensitive Block Copolymer Hydrogel with Embedded Catanionic Vesicles as a Localized Doxorubicin Delivery Platform for Melanoma. (2026/07/26) ♡
- A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma. (2026/07/25) ♡
- Thioredoxin interacting protein (TXNIP), a redox regulator, mediates the EPAC-RAP1 signaling dependency of primary melanoma. (2026/07/25) ♡
- The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma. (2026/07/24) ♡
- Autocrine CysLT(1)R-ERK/YAP signaling drives melanoma progression and reveals a targetable oncogenic GPCR axis. (2026/07/24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021. (2026/07/24) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.